Advancing CAR T-cell Therapy in Difficult to Treat Cancers: An Interview with Precigen’s Helen Sabze Ovarian 3 Mins Read0 In this edition of The Onco’Zine Brief, Peter Hofland talking with Helen Sabzevari, the president of Precigen. Precigen is a…
